1. Home
  2. Browse
  3. HRA004391
HRA004391
   HRA004391.xlsx
Title:
Single-cell landscape of lung adenocarcinoma accepting neoadjuvant immunotherapy
Release date:
2025-04-18
Description:
This study profiled the molecular landscape of the tumors samples from lung adenocarcinoma patients accepting neoadjuvant therapy.
Data Accessibility:   
Controlled access Request Data
BioProject:
PRJCA016193
Study type:
Disease Study
Disease name:
lung adenocarcinoma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
HDAC002497
DAC name:
Lung adenocarcinoma Team
Contact person:
Yang Zhenlin
Email:
yangzl@cicams.ac.cn
Description:
The datasets are under controlled access, and Lung adenocarcinoma Team determine access permissions. Applicants who want to obtain the datasets need to submit a formal application through the institutional email and acknowledge that the intellectual property of this data belongs to the data submitter (National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences).
Individuals & samples
Files
Request Data
Submitter:   Yang Zhenlin / yangzl@cicams.ac.cn
Organization:   National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences
Submission date:   2023-04-18
Requests:   -